- Home
- CPZ vs SMLR Comparison
CPZ vs SMLR Comparison
Compare CPZ & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPZ
- SMLR
- Stock Information
- Founded
- CPZ 2019
- SMLR 2007
- Country
- CPZ United States
- SMLR United States
- Employees
- CPZ N/A
- SMLR N/A
- Industry
- CPZ Trusts Except Educational Religious and Charitable
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CPZ Finance
- SMLR Health Care
- Exchange
- CPZ Nasdaq
- SMLR Nasdaq
- Market Cap
- CPZ 305.7M
- SMLR 289.5M
- IPO Year
- CPZ N/A
- SMLR 2014
- Fundamental
- Price
- CPZ $15.44
- SMLR $71.84
- Analyst Decision
- CPZ
- SMLR
- Analyst Count
- CPZ 0
- SMLR 0
- Target Price
- CPZ N/A
- SMLR N/A
- AVG Volume (30 Days)
- CPZ 63.0K
- SMLR 1.1M
- Earning Date
- CPZ 01-01-0001
- SMLR 11-04-2024
- Dividend Yield
- CPZ 11.07%
- SMLR N/A
- EPS Growth
- CPZ N/A
- SMLR N/A
- EPS
- CPZ N/A
- SMLR 2.04
- Revenue
- CPZ N/A
- SMLR $58,938,000.00
- Revenue This Year
- CPZ N/A
- SMLR N/A
- Revenue Next Year
- CPZ N/A
- SMLR N/A
- P/E Ratio
- CPZ N/A
- SMLR $31.66
- Revenue Growth
- CPZ N/A
- SMLR N/A
- 52 Week Low
- CPZ $13.17
- SMLR $20.88
- 52 Week High
- CPZ $16.11
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- CPZ 45.91
- SMLR 67.75
- Support Level
- CPZ $15.35
- SMLR $58.75
- Resistance Level
- CPZ $15.68
- SMLR $65.97
- Average True Range (ATR)
- CPZ 0.21
- SMLR 7.71
- MACD
- CPZ -0.01
- SMLR -0.05
- Stochastic Oscillator
- CPZ 19.15
- SMLR 72.28
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.